Migfilin promotes migration and invasion in glioma by driving EGFR and MMP-2 signalings: A positive feedback loop regulation

Yunwei Ou; Qingnan Wu; Chuanyue Wu; Xuefeng Liu; Yongmei Song; Qimin Zhan

doi:10.1016/j.jgg.2017.09.008

Volume 44 Issue 12

Dec. 2017

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2017 > 44(12): 557-565

PDF( 3078 KB)

Migfilin promotes migration and invasion in glioma by driving EGFR and MMP-2 signalings: A positive feedback loop regulation

doi: 10.1016/j.jgg.2017.09.008

Yunwei Ou^{a, b, c, f},
Qingnan Wu^c,
Chuanyue Wu^{d, e},
Xuefeng Liu^c,
Yongmei Song^c,
Qimin Zhan^c

a
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
b
Beijing Neurosurgical Institute, Capital Medical University, Beijing 100050, China
c
State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
d
Department of Pathology, University of Pittsburgh, Pittsburgh 15261, USA
e
Department of Biology and Shenzhen Key Laboratory of Cell Microenvironment, South University of Science and Technology of China, Shenzhen 518055, China
f
China National Clinical Research Center for Neurological Diseases, Beijing 100050, China

More Information

Corresponding author: E-mail address: symlh2006@163.com (Yongmei Song); E-mail address: qiminzhan@vip.163.com (Qimin Zhan)
Received Date: 2017-06-05
Accepted Date: 2017-09-17
Rev Recd Date: 2017-09-04

Available Online: 2017-10-16

Publish Date: 2017-12-20

Abstract

Abstract

Glioma is the most common type of primary brain tumors in the central nervous system (CNS). Migfilin occurs in human glioma and enhances cellular motility via the epidermal growth factor receptor (EGFR) pathway. However, the underlying molecular mechanism is not fully understood. In this study, we found that Migfilin promoted matrix metalloproteinase-2 (MMP-2) activity, and restrained the expression of tissue inhibitor of metalloproteinase 2 (TIMP2), which is an MMP-2 inhibitor. Functional and structural studies showed that the LIM1 domain of Migfilin was required for Migfilin-mediated TIMP2 expression inhibition and MMP-2 activity, and was also necessary in promoting cell motility. Furthermore, Migfilin-induced EGFR phosphorylation was greatly reduced by MMP-2 inhibitor (GM6001) or siRNA, while Migfilin-induced MMP-2 activation was also blocked by the EGFR inhibitor (AG1478) or siRNA. MMP-2 and EGFR inhibitors and their siRNAs can block Migfilin-induced migration and invasion, respectively. These results demonstrated that EGFR and MMP-2 signalings may form a positive feedback loop to enhance Migfilin-induced migration and invasion. Finally, we detected that the expression of Migfilin, EGFR phosphorylation (Tyr1173) and MMP-2 activity had a positive correlation in the clinical glioma sample. Taken together, these results suggest that Migfilin is a critical regulator in cellular motility by driving the EGFR-MMP-2 feedback loop, and may be considered as a potential therapeutic target in glioma.
- Glioma,
- Migfilin,
- MMP-2,
- EGFR,
- Motility

FullText(HTML)

References(28)

References

[1]	Akazawa, H., Kudoh, S., Mochizuki, N. et al. A novel LIM protein Cal promotes cardiac differentiation by association with CSX/NKX2-5 J. Cell Biol., 164 (2004),pp. 395-405
[2]	Chamberlain, M.C., Sanson, M. Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes Neurology, 84 (2015),p. 2007
[3]	Chicoine, M.R., Silbergeld, D.L. Cancer, 75 (1995),pp. 2904-2909
[4]	Das, M., Ithychanda, S.S., Qin, J. et al. Migfilin and filamin as regulators of integrin activation in endothelial cells and neutrophils PLoS One, 6 (2011),p. e26355
[5]	En-Nia, A., Reisdorff, J., Stefanidis, I. et al. Mesangial cell gelatinase A synthesis is attenuated by oscillating hyperbaric pressure Biochem. J., 362 (2002),pp. 693-700
[6]	Fan, J., Ou, Y.W., Wu, C.Y. et al. Acta Pharmacol. Sin., 33 (2012),pp. 1301-1310
[7]	Gkretsi, V., Bogdanos, D.P. Experimental evidence of Migfilin as a new therapeutic target of hepatocellular carcinoma metastasis Exp. Cell Res., 334 (2015),pp. 219-227
[8]	Gkretsi, V., Papanikolaou, V., Zacharia, L.C. et al. Anticancer Res., 33 (2013),pp. 1977-1981
[9]	Gkretsi, V., Zhang, Y., Tu, Y. et al. Physical and functional association of migfilin with cell-cell adhesions J. Cell Sci., 118 (2005),pp. 697-710
[10]	Gong, M., Meng, L., Jiang, B. et al. p37 from Mycoplasma hyorhinis promotes cancer cell invasiveness and metastasis through activation of MMP-2 and followed by phosphorylation of EGFR Mol. Canc. Therapeut., 7 (2008),pp. 530-537
[11]	He, H., Ding, F., Li, S. et al. Expression of migfilin is increased in esophageal cancer and represses the Akt-beta-catenin activation Am. J. Cancer Res., 4 (2014),pp. 270-278
[12]	He, H., Ding, F., Li, Y. et al. Migfilin regulates esophageal cancer cell motility through promoting GSK-3beta-mediated degradation of beta-catenin Mol. Cancer Res., 10 (2012),pp. 273-281
[13]	Kheradmand, F., Rishi, K., Werb, Z. Signaling through the EGF receptor controls lung morphogenesis in part by regulating MT1-MMP-mediated activation of gelatinase A/MMP2 J. Cell Sci., 115 (2002),pp. 839-848
[14]	Lad, Y., Jiang, P., Ruskamo, S. et al. Structural basis of the migfilin-filamin interaction and competition with integrin beta tails J. Biol. Chem., 283 (2008),pp. 35154-35163
[15]	Liu, Z., Lu, D., Wang, X. et al. Kindlin-2 phosphorylation by Src at Y193 enhances Src activity and is involved in Migfilin recruitment to the focal adhesions FEBS Lett., 589 (2015),pp. 2001-2010
[16]	Louis, D.N., Ohgaki, H., Wiestler, O.D. et al. The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol., 114 (2007),pp. 97-109
[17]	Louis, D.N., Perry, A., Reifenberger, G. et al. The 2016 World Health organization classification of tumors of the central nervous system: a summary Acta Neuropathol., 131 (2016),pp. 803-820
[18]	Mou, L., Kang, Y., Zhou, Y. et al. Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP) J. Biol. Chem., 288 (2013),pp. 306-318
[19]	Ohgaki, H., Kleihues, P. Genetic pathways to primary and secondary glioblastoma Am. J. Pathol., 170 (2007),pp. 1445-1453
[20]	Olson, M.W., Gervasi, D.C., Mobashery, S. et al. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 J. Biol. Chem., 272 (1997),pp. 29975-29983
[21]	Ou, Y., Ma, L., Dong, L. et al. Migfilin protein promotes migration and invasion in human glioma through epidermal growth factor receptor-mediated phospholipase C-gamma and STAT3 protein signaling pathways J. Biol. Chem., 287 (2012),pp. 32394-32405
[22]	Stewart, L.A. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet, 359 (2002),pp. 1011-1018
[23]	Tu, Y., Wu, S., Shi, X. et al. Migfilin and Mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation Cell, 113 (2003),pp. 37-47
[24]	VanMeter, T.E., Rooprai, H.K., Kibble, M.M. et al. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis J. Neurooncol, 53 (2001),pp. 213-235
[25]	Role of matrix proteases in processing enamel proteins Connect. Tissue Res., 39 (1998),pp. 69-73
[26]	Xie, T.X., Wei, D., Liu, M. et al. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis Oncogene, 23 (2004),pp. 3550-3560
[27]	Yue, X., Lan, F., Yang, W. et al. Interruption of beta-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells Brain Res., 1366 (2010),pp. 27-37
[28]	Zhang, Y., Tu, Y., Gkretsi, V. et al. Migfilin interacts with vasodilator-stimulated phosphoprotein (VASP) and regulates VASP localization to cell-matrix adhesions and migration J. Biol. Chem., 281 (2006),pp. 12397-12407